NCT06704958 Augmented Momentary Personal Ecological Risk Evaluation
| NCT ID | NCT06704958 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Suicidal Ideation |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-25 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-09-25 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this intervention study is to co-design and test an Ecological Momentary Assessment (EMA) prototype tool with young adults aged 16-30 experiencing suicidality to see if it is an acceptable and usable clinical tool for risk management. The main study aims are: * To co-design a prototype EMA suicide risk monitoring system with patients and health care provider input using Human Centered Design (HCD) methods. * To test the developed EMA protype with providers and their young adult patients aged 16-30 experiencing suicidality to determine if the EMA prototype is an acceptable and usable clinical tool. Young adult participants receiving care for active suicidal ideation will * Download and use the EMA prototype for a total of two months. * Complete 3 online surveys at 0, 1 and 2 months after enrolled in the study.
Eligibility Criteria
Inclusion Criteria: * Young adults (age 16-30 years) * Receiving care at University of Washington Primary Care for suicidal ideation as determined by Electronic Health Record problem list or PHQ-9 suicide risk item \>0 in previous year and/or recent (past year) history of suicide attempt and/or active suicidal ideation. * Ability to consent to participate Exclusion Criteria: * Age \<16 or \>30, * Non-English speaking * No smart phone access * Any clinical medical/psychiatric condition, severity of that condition, or life situation that would compromise safe and voluntary study participation.
Contact & Investigator
Ian M Bennett, MD, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT06704958 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 30 Years, studying Suicidal Ideation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06704958 currently recruiting?
Yes, NCT06704958 is actively recruiting participants. Contact the research team at mindyv@uw.edu for enrollment information.
Where is the NCT06704958 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT06704958 clinical trial?
NCT06704958 is sponsored by University of Washington. The principal investigator is Ian M Bennett, MD, PhD at University of Washington. The trial plans to enroll 50 participants.